Screener
Pulse Biosciences, Inc. PLSE Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Pulse Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Pulse Biosciences, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026288
FAQ
- What is Pulse Biosciences, Inc.'s return on equity?
- Pulse Biosciences, Inc. (PLSE) reported return on equity of -78.5% in Q2 2026.
- How has Pulse Biosciences, Inc.'s return on equity changed year-over-year?
- Pulse Biosciences, Inc.'s return on equity increased by 24.2% year-over-year, from -103.5% to -78.5%.
- What is the long-term trend for Pulse Biosciences, Inc.'s return on equity?
- Over 3 years (2020 to 2025), Pulse Biosciences, Inc.'s return on equity has grown at a -26.3% compound annual growth rate (CAGR), from -185.9% to -74.4%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Pulse Biosciences, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude